Post-earnings recap
Reported
Tue, Jan 16, 2024
EPS actual
$-0.01
EPS est.
—
EPS surprise
—
1-day move
-6.40%
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytoDyn Inc. reported a loss per share of $-0.01, but did not provide revenue figures or any guidance. The stock reacted negatively, dropping 6.40%, indicating investor concerns about the company's performance and future prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.01 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.